Obermatt
See Similar Stocks →

Korea United Pharm

KSC:033270 · KR7033270000
PharmaceuticalsSmall

360° View

90
Price/Sales60
Price/Earnings64
Price/Book76
Dividend Yield99
Revenue Growth1
Profit Growth45
Capital Growth74
TSR 52w47
Leverage67
Liquidity85
Refinancing62
Combined79
Analyst Opinions34
Pro Holdings65
Opinion Changes50
Market Pulse100

Profile

CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
TypePublic Company
ExchangeKOSE
Employees26
Websitekup.co.kr
ISINKR7033270000
Last UpdateApr 2, 2026
Index & Theme
CardiovascularOncologyRespiratoryAllergyCentral Nervous SystemHealth CarePharmaceutical

Description

Analysis

Korea United Pharm's 360° View rank of 90 places it among the strongest overall — better than 90% of its true peers.

It's growing slowly (27) and looks cheap versus peers (94). On safety it is very well financed (87), and the market shows strongly positive sentiment (82). Taken together, its Combined rank of 79 reads as among the strongest overall.

360° rank · history

1007550250
90
2026

All-time high

90

Jun 2026

All-time low

67

Mar 2026

Average rank

79

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
60
—
—
—
Price/Earnings
64
—
—
—
Price/Book
76
—
—
—
Dividend Yield
99
—
—
—
Value (overall)
94
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Korea United Pharm with its peers
Kukje Pharma
KSC:002720
43
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Hana Pharm
KSC:293480
88
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
PharmGen Science
KSC:004720
74
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Samsung Pharm
KSC:001360
—
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Kyongbo Pharmaceutical
KSC:214390
11
CountrySouth Korea
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Redox
ASX:RDX
75
CountryAustralia
IndustryTrading Companies & Distributors
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →